Background. Aquaporin-2 (AQP-2) is an arginine vasopressin (AVP)-regulated water channel in kidney collecting duct cells. The present study was undertaken to determine whether a change in tonicity could directly regulate the AQP-2 gene in an in vitro experiment.
Introduction
Aquaporin-2 (AQP-2) is an arginine vasopressin (AVP)-regulated water channel in renal collecting duct cells [1, 2] . The subsequent activation of vasopressin V 2 receptors (V 2 Rs) initiates the translocation of AQP-2-bearing vesicles from the cytosol to the plasma membrane within minutes, in which AQP-2 is inserted by an exocytosis-like process (short-term regulation) [3] . AVP also induces AQP-2 transcription by the cAMP-responsive element (CRE), and regulates the abundance of AQP-2 protein [4, 5] . This is called longterm regulation. Therefore, AVP plays a pivotal role in the on-off regulation of the cellular trafficking of AQP-2 and the synthesis of AQP-2 in collecting duct cells.
However, there is no evidence that tonicity directly regulates the expression of AQP-2. In a state of chronic AVP excess (SIADH) [6, 7] , the antidiuretic action of V 2 R is attenuated, resulting in some water diuresis. This state has been termed as renal escape from AVPinduced antidiuresis. Several studies including our in vivo experiment recently have demonstrated that the upregulation of AQP-2 mRNA and protein expression was significantly attenuated in experimental rats with SIADH, compared with rats with an excess of AVP in the absence of volume expansion [8, 9] . Therefore, either hypotonicity or volume expansion may directly regulate the post-receptor signalling of AVP in renal collecting duct cells [9] .
A recent in vitro study may suggest the presence of osmotic control of AQP-2 transcription in primary culture of inner medullary collecting duct cells [10] , which was probably mediated through the tonicity response enhancer element (TonE), (C/T)GGAAnnn (C/T)n(C/T), located at bp À570 to À560 of the AQP-2 promoter [11, 12] . However, the exact mechanism of transcriptional regulation by hypertonicity of the AQP-2 promoter has not been determined yet. Among the AQP family, it is evident that the expression of AQP-1, AQP-4 and AQP-9 was controlled by hypertonicity not via the TonE sequence [13, 14] .
In this study, we confirmed AVP-independent regulation of the AQP-2 promoter by hypertonicity, and investigated the site for hyperosmotic stimulation in the gene regulatory element of murine AQP-2. We found that the À6.1 to À4.3 kb 5 0 -flanking region of the AQP-2 promoter is the main hypertonicityresponsive region rather than TonE located at nucleotides À570 to À560.
Materials and methods

Cell culture
Madin-Darby canine kidney (MDCK) (CCL34) cells were purchased from the American Type Culture Collection (Manassas, VA). The number of passage of the cells was 49. Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5 mmol/l D-glucose, penicillin G (100 U/ml), streptomycin (100 mg/ml) and 10% fetal bovine serum (FBS). To clarify the effects of hypertonicity, all experiments were performed in medium containing a low concentration of FBS (1%).
Preparation of hypertonic medium
The hyperosmotic medium (600 mosmol/kg) was prepared by adding NaCl and urea at a molar ratio of 1:2 into the isotonic medium [15] , which is close to the physiological condition in the renal medulla. Urea is a permeable solute, and does not make an osmotic gradient. Therefore, the medium showed $450 mosmol/kg as the hypertonicity achieved by NaCl. The advantage is based on good viability and stability of cultured cells under long-term exposure to hypertonic conditions. Hyperosmotic medium (600 mosmol/kg) achieved by adding only urea was also used in some experiments.
Plasmid constructions for reporter assay
To make SfiI and EcoRI sites in the multiple cloning site of pGL3-basic vector (Promega, Madison, WI), annealed synthetic oligonucleotide fragments, 5 0 -TCGAGGGCCT GTACGGCCTCGCGAAGAATTCGATATCA-3 0 and 5 0 -AGCTTGATATCGAATTCTTCGCGAGGCCGTACAG GCCC-3 0 , were inserted between the XhoI and HindIII restriction sites, and named modified-pGL3-basic vector. Then we cloned the SfiI and EcoRI sites into the multiple cloning site of pGL3-promoter vector (Promega, Madison, WI) as well as pGL3-basic vector, and annealed synthetic oligonucleotide fragments, 5 0 -TCGAGGGCCTGTACGGC CTCGCGAAGAATTCGATATCA-3 0 and 5 0 -TCGAGGA TATCGAATTCTTCGCGAGGCCGTACAGGCCC-3 0 , were inserted between the XhoI restriction site, and named modified-pGL3-promoter vector. We isolated and characterized the murine AQP-2 gene promoter region. Approximately 5 Â 10 5 phage clones from a mouse genomic library (Straytagene, La Jolla, CA) were screened with exon 1 of murine AQP-2 cDNA labelled with [a-32 P]dCTP by random printing. Positive clones were purified and characterized by restriction endonuclease mapping and Southern blot analysis. Positive DNA fragments were subcloned into pSPORT1 vector (Life Technologies). We selected the longest clone and sequenced it near the 5 0 side by Taq Dye Terminator Cycle Sequencing Kit (Perkin-Elmer, Culver City, CA). The murine AQP-2 gene and a total of 14 kb of flanking sequence ($10.5 kb from the 5 0 side and 3.5 kb from the 3 0 side of the initiation codon) into pSPORT-1 (Invitrogen) from overlapping clones. In this study, all primers for polymerase chain reaction (PCR) amplifications of the murine AQP-2 promoter region were constructed according to the sequencing data of the murine AQP-2 gene reported by Nelson et al.
(National Center for Biotechnology, National Institute of Health, accession number. AY055468). Introduction of SfiI and EcoRI sites was performed by PCR using upper primers
0 (from bp À2622 to À2603) and 5 0 -ACTCGAATG GCCTGTACGGCCTGAGGCAGCTCCATGGGGTA-3 0 (from bp À356 to À337), and lower primer 5 0 -CTAGC CAGAATTCATGCTGCTCGGCCTTCTGAGCG-3 0 (from bp 1 to À20). After cutting these PCR products with SfiI and EcoRI, the fragments were cloned into the modifiedpGL3-basic vector. These constructs contained 9.5, 6.1, 4.3, 2.6 and 0.36 kb 5 0 -flanking regions of the AQP-2 promoter, and were named À9.5AQP2, À6.1AQP2, À4.3 AQP2, À2.6 AQP2 and À0.36AQP2, respectively. We also cut out 1.1 kb of 5 0 -flanking region between the HindIII sites from the À9.5AQP2, and inserted this fragment into the HindIII site of modified-pGL3-basic vector (À1.1AQP2). To delete the TonE-binding protein (TonEBP)-binding site (at bp À570), we cloned À9.5 to À1.1 kb of the 5 0 side of the murine AQP-2 gene. Introduction of SfiI and EcoRI sites was performed by PCR using the upper primer 5 0 -ACTCGAATGGCCTG TACGGCCGAAACATCACACTTAGGAAG-3 0 (from bp À9516 to À9497) and the lower primer 5 0 -CTAGCCAGA ATTCAAGCTTGGTCAGTGTTCTGC-3 0 (from bp À1103 to À1122). After cutting these PCR products by SfiI and EcoRI, these fragments were cloned into the modified-pGL3-promoter vector, and named 8.4AQP2. This vector contains À9.5 to À1.1 kb of the 5 0 side of the murine AQP-2 gene. Therefore, the TonEBP-binding site and CRE were deleted.
The cDNA of human TonEBP was cloned by Miyakawa et al. [16] , and the gene had a large open reading frame (ORF) of 1455 amino acids. The protein has a bipartite structure, a DNA-binding domain in the N-terminus and a 510 K. Kasono et al.
transactivation domain toward the C-terminus. A truncated TonEBP containing only the DNA-binding site (N-terminal 472 amino acids) showed dominant-negative activity on TonE-mediated stimulation of reporter gene expression [16, 17] . TonEBP and the truncated TonEBP cloned into the multiple cloning site of pcDNA3, and named pTonEBP and pDNTonEBP, respectively, were kindly provided by Professor H. M. Kwon, Department of Medicine, Johns Hopkins University, Baltimore, MD.
Transient transfections
MDCK cells (5 Â 10 4 ) were seeded into 24-well tissue culture plates (16 mm well diameter) and grown for 24 h. The cells were transfected with 0.5 mg of DNA/well of the vectors described above. Transfections were performed using SuperFect (QIAGEN, Hilden, Germany) according to the manufacturer's instructions. Hypertonic stress was induced by the 600 mosmol/kg medium. Regular DMEM was added to cells exposed to isotonic conditions. The p38 mitogenactivated protein (MAP) kinase inhibitor SB203580 or the MEK inhibitor U0126 (Promega, Madison, WI) dissolved in dimethylsulfoxide (DMSO) was added to achieve the indicated concentrations 1 h before the hypertonic conditions were achieved. DMSO was also added to the controls to ensure that all wells had the same concentration of DMSO.
Luciferase and protein assay
Luciferase (Luc) activities were measured after 48 h incubation. In some experiments, 0.5 mmol/l of dibutyryl cAMP (DBcAMP) (Sigma-Aldrich, St Louis, MO) was added to the medium 6 h before the Luc assay. Cell lysis buffer (100 ml/well) was added to each well. A 10 ml aliquot of the lysate was used for protein assay using Bio-Rad protein assay reagent (BioRad, Hercules, CA). The rest of the lysate was analysed for Luc activity using the Luciferase Assay System (Promega) and a luminometer TD-2020 (Turner Designs, Sunnyvale, CA). Luc activity was standardized by the amount of protein and presented as fold induction usually compared with the control wells cultured in the isotonic medium in the absence of DBcAMP.
Statistical analysis
Results were expressed as the mean±SE. Statistical significance among experimental groups was assessed by analysis of variance (two-way ANOVA) and Student's t-test, using a threshold for significance of P<0.05.
Results
AQP-2 promoter is stimulated by DBcAMP and hypertonicity
A 6 h exposure of cells to 0.5 mmol/l DBcAMP significantly increased the fold induction of Luc activities of À1.1AQP2 and À9.5AQP2 by 1.79±0.47 and 1.58±0.37, respectively. Hypertonicity (600 mosmol/kg) significantly increased the fold induction of Luc activity of À9.5AQP2 by 1.64±0.18. However, the Luc activity of À1.1AQP2, which has both TonE at bp À570 to À560 and CRE at bp À310 to À304, was unexpectedly not stimulated by hypertonicity (Figure 1 ). 8.4AQP2 does not include TonE and CRE. However, hypertonicity still activated the Luc activity of 8.4AQP2 by 1.77±0.18. Hypertonic stimulation upregulated À9.5AQP2 in a dose-dependent manner. Hypertonicity >500 mosmol/kg significantly increased the Luc activity of À9.5AQP2 (data not shown). Hyperosmolality (not hypertonicity) of 600 mosmol/ kg achieved only by the permeable solute urea did not affect the Luc activity of À9.5AQP2 (data not shown). Then, we examined the effects of both hypertonicity and DBcAMP on the Luc activity (Figure 2) . In this experiment, hypertonicity and DBcAMP increased the fold induction of Luc activities of À9.5AQP2 by 1.25±0.05 and 1.40±0.16, respectively. Co-stimulation of hypertonicity and DBcAMP synergistically increased the Luc activity of À9.5AQP2 by 1.89±0.11, but the Luc activity of À1.1AQP2 induced by DBcAMP was not significantly altered by the co-existence of hypertonicity. These results indicated that hypertonicity directly stimulated the AQP-2 promoter region in À9.5AQP2. In our experimental conditions, TonE was not significantly activated by hypertonicity.
Location of the hypertonicity-responsive region in the AQP-2 promoter
The promoter of the murine AQP-2 gene contains binding sites for CREB and TonEBP, and these elements are located at nucleotides À310 to À304 (GACGTCA) and À570 to À560 (TGGAAATTTGT), respectively. We made several constructs, which were named À0.36, À1.1, À2.6, À4.3, À6.1 and À9.5AQP2. All of the constructs transfected in MDCK cells usually showed >100-fold greater Luc activity than pGL3-basic vector (data not shown). Figure 3 shows the fold induction of Luc activities under hypertonic conditions (600 mosmol/kg) compared with isotonic conditions. The fold induction of Luc activities of À0.36, À1.1, À2.6, À4.3, À6.1 and À9.5AQP2 were 1.03±0.35, 0.80±0.13, 1.08±0.13, 0.83±0.07, 1.69±0.29 and 1.62±0.36, respectively. Only the Luc activities of À6.1 and À9.5AQP2 were significantly increased. These results suggested that the main hypertonicity-responsive region or regions were located in À6.1 through À4.3 kb of the 5 0 -flanking region of the murine AQP-2 promoter.
Effects of MAP kinase inhibitors and DNTonEBP on AQP-2 promoter activity
We next examined the effects of MAP kinase inhibitors on the promoter activity of À6.1AQP2. Neither SB203580 (p38 MAP kinase inhibitor) nor U0126 (MEK inhibitor) affected the Luc activity of À6.1 AQP2 (Figure 4) . Hypertonicity significantly increased the fold induction of Luc activity in MDCK cells co-transfected with À6.1AQP2 (0.5 mg/well) and control plasmid, pcDNA3 (1 mg/well), by 1.57±0.15. Co-transfection with À6.1AQP2 (0.5 mg/well) and pDNTonEBP (1 mg/well) did not affect the fold induction of the hypertonicity-induced Luc activity of À6.1AQP2 ( Figure 5 ). We cloned the double TonE sequence into À0.36AQP2 (pTonE2). Hypertonicity significantly increased the fold induction of Luc activity in MDCK cells co-transfected with pTonE2 and pcDNA3. Co-transfection of pDNTonEBP with pTonE2 significantly reduced the hypertonicityinduced Luc activity (data not shown).
Effect of TonEBP on AQP-2 promoter activity
To achieve the overexpression of TonEBP, we performed the transfection of À1.1AQP2 or À6.1AQP2 with pTonEBP. The promoter of pTonEBP is the cytomegalovirus (CMV) promoter, therefore the transcription of TonEBP may not be affected by hypertonicity. Co-transfection with À1.1AQP2 (0.5 mg/ well) and pTonEBP (0.5 or 1 mg/well) in the isotonic medium remarkably augmented the Luc activity by 1.65±0.06 and 4.09±0.47, respectively. In the same experiment, the co-existence of hypertonicity and pTonEBP did not stimulate the Luc activity of À1.1AQP2. pTonEBP (0.5 or 1 mg/well) in the isotonic medium also increased the fold induction of Luc activity of À6.1AQP2 by 1.92±0.23 and 6.42±1.24, respectively. In this case, hypertonicity further enhanced the Luc activity of À6.1AQP2 under the overexpression of TonEBP (P<0.05; Figure 6 ).
Discussion
The 5 0 -flanking region of AQP-2 has a CRE located at bp À310 to À304 (GACGTCA) and a TonE located at bp À570 to À560 (TGGAAATTTGT) [4, 10] . It is therefore speculated that AQP-2 transcription is regulated by hypertonicity.
The present study demonstrated the hypertonicityresponsive transcriptional regulation of the AQP-2 gene, by analysing the Luc assay of the reporter constructs containing the 5 0 -flanking region of the AQP-2 gene transfected into MDCK cells. We examined the 5 0 -flanking region of the AQP-2 gene for up to À9.5 kb from the initial codon of AQP-2. Hypertonic stimulation did not significantly activate the AQP-2 promoter with <4.3 kb of the 5 0 -flanking region, though TonE is contained in the AQP-2 promoter at nucleotides À570 to À560. Furthermore, 8.4AQP2, the construct which contains no TonE and CRE, was still activated by hypertonic stimulation as well as À6.1AQP2. The TonE consensus sequence, (C/T) GGAAnnn(C/T)n(C/T), initially was identified as the cis-acting element responsible for hypertonic regulation [18] . TonE mediates the transcriptional regulation of several genes, including sodium/myo-inositol cotransporter, sodium/chloride/betaine co-transporter, and aldose reductase in response to hypertonicity [10, 11, 19] . TonEBP, a transcription factor that stimulates TonE, has been cloned using the yeast one-hybrid assay [16] . It is possible that MDCK cells do not produce a sufficient amount of TonEBP to stimulate TonE in our experimental conditions, or that TonE in the murine AQP-2 promoter region has low sensitivity to the action of TonEBP. Rim et al. [12] reported that five TonEs were scattered over 50 kb in the gene regulatory element of the sodium/myo-inositol co-transporter gene. The exposure of cells to hypertonicity increased the binding of TonEBP to these TonE sites, and together they stimulated transcription under hypertonic conditions. Although we have no data regarding the nucleotide sequence further than 10.5 kb of the 5 0 -flanking region of the AQP-2 gene, there is only one TonE located in the 5 0 -flanking region Canine MDCK cells may not be the ideal model system to study gene regulation of murine AQP2. When the series of experiments was started, the transfected constructs were not well expressed in mouse IMCD3 cells, and the transfection ratio of mouse IMCD3 cells was <1% using SuperFect. Thus MDCK cells were employed to evaluate the AQP-2 promoter activity. The transfection ratio of MDCK cells was >20%. In our experimental system using MDCK cells, human TonEBP stimulated the Luc activity of constructs containing TonE well. Therefore, we speculate that the regulation of gene expression by hypertonicity may use the common pathway between many species.
The study using the fusion genes of various lengths of the AQP-2 promoter with the Luc reporter gene showed that constructs containing >6.1 kb of the 5 0 -flanking region had hypertonicity-induced Luc activity. The hypertonicity-induced Luc activity of À6.1AQP2 was found in hypertonic medium, by adding NaCl, but not urea. Urea penetrates the cell membrane, and does not produce a sufficient tonicity gradient. The osmolality of the medium was increased by adding NaCl and urea at a molar ratio of 1:2 in most of the present experiments [15] . The cells retained their viability well in the hypertonic medium containing both NaCl and urea. Additionally, this hypertonic medium showed a stable effect on the promoter activity of À6.1AQP2 and À9.5AQP2 rather than the hypertonic medium achieved by only NaCl.
We also examined the effect of DNTonEBP on the AQP-2 promoter. When the vector expressing DNTonEBP (pDNTonEBP) was co-transfected with À6.1AQP2, the Luc activity remained elevated after the cells were exposed to the hypertonic medium. Overexpression of TonEBP strongly stimulated the promoter activity of both À1.1AQP2 and À6.1AQP2. Hypertoxicity further increased the LUC activity of À6.1 AQP2, but not that of À1.1 AQP2, under the over expression of TonEBP. In addition, the inhibitors of p38 MAP kinase and MEK, i.e. SB203580 and U0126, did not alter the hypertonicity-induced promoter activity of À6.1AQP2. As previously reported [20] , p38 MAP kinase and MEK participate in cellular signal transduction to the hypertonicity-induced AQP-1 promoter activity. The AQP-2 promoter for up to À10.5 kb does not include the tonicity-responsive element (GCTCCCCCC) located in the AQP-1 promoter. The present findings therefore indicate that the structure of the tonicity-responsive region at kb À6.1 to À4.3 is different from that of classical TonE or the tonicity-responsive element in the AQP-1 promoter. Further studies will be necessary to elucidate the exact sequence of such a TonE-independent tonicityresponsive element in the 5 0 -flanking region of the AQP-2 gene.
Since MDCK cells had no receptor for AVP, the effect of DBcAMP mimics the AVP-regulated transcription of the AQP-2 gene. The DBcAMP-induced Luc activity of À9.5AQP2 was augmented synergistically by hypertonicity, but it was not found in À1.1AQP2. The observation suggests that the tonicity-responsive region in À9.5AQP2 facilitates the synergism with CRE.
In conclusion, we demonstrated that there is an additional tonicity-responsive region in the 5 0 -flanking region of the AQP-2 gene located at kb À6.1 to À4.3 as well as the classical TonE. Hypertonic stimulation participates in a synergistic effect on AVP-induced AQP-2 transcription.
